LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
51 hedge funds and large institutions have $97.5M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$470K | |
| 2 | +$308K | |
| 3 | +$250K | |
| 4 |
BlackRock
New York
|
+$196K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$90K |
Top Sellers
| 1 | -$6.77M | |
| 2 | -$399K | |
| 3 | -$395K | |
| 4 |
SC
Samlyn Capital
New York
|
-$119K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$111K |